JNE Partners LLP - Q3 2023 holdings

$85.5 Million is the total value of JNE Partners LLP's 5 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 80.0% .

 Value Shares↓ Weighting
MU  MICRON TECHNOLOGY INC$35,246,343
+7.8%
518,1000.0%41.21%
-27.5%
NewLIBERTY MEDIA CORP DEL$26,813,130835,300
+100.0%
31.35%
NewATLANTA BRAVES HLDGS INC$18,155,842508,140
+100.0%
21.23%
NG  NOVAGOLD RES INC$5,020,401
-3.8%
1,307,3960.0%5.87%
-35.3%
 WALDENCAST PLC*w exp 07/27/202$299,166
+38.3%
333,3330.0%0.35%
-6.9%
BATRK ExitLIBERTY MEDIA CORP DEL$0-202,000
-100.0%
-13.92%
EOCWU ExitELLIOTT OPPORTUNITY II CORPunit 99/99/9999$0-1,100,000
-100.0%
-19.78%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings